CN Patent

CN111592528A — 氘代的哒嗪酮及其衍生物和药物组合物

Assigned to Suzhou Zelgen Biopharmaceutical Co Ltd · Expires 2020-08-28 · 6y expired

What this patent protects

本发明涉及氘代的哒嗪酮及其衍生物和药物组合物。具体地，本发明化合物具有式(I)所示结构，其中各基团和取代基的定义如说明书中所述。所述化合物对甲状腺激素β受体有选择性激动作用和/或更好药效学性能。

USPTO Abstract

本发明涉及氘代的哒嗪酮及其衍生物和药物组合物。具体地，本发明化合物具有式(I)所示结构，其中各基团和取代基的定义如说明书中所述。所述化合物对甲状腺激素β受体有选择性激动作用和/或更好药效学性能。

Drugs covered by this patent

Patent Metadata

Patent number
CN111592528A
Jurisdiction
CN
Classification
—
Expires
2020-08-28
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Zelgen Biopharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.